Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Baumelou

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Bulletin De L'Academie Nationale De Medecine|August 1, 2008
[Public health benefits of non prescription medicines and self care]Alain Baumelou
The New England Journal of Medicine|January 9, 2010
Renal failure in cirrhosisHassane Izzedine, Alain Baumelou
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2007
Acute renal failure in HIV patientsHassane Izzedine, Alain Baumelou, Gilbert Deray
Kidney International|February 27, 2010
Idiopathic renal arteriovenous fistulaeHassane Izzedine, Alain Baumelou, Philippe Cluzel
Nephrologie & Therapeutique|March 22, 2007
[Hemoglobin target in hemodialysis patients]Lucile Mercadal, Gilbert Deray, Alain Baumelou
La Revue Du Praticien|March 8, 2006
[Medication use in older patients with chronic renal failure]Alain Baumelou, Vincent Launay Vacher, Marc Verny
American Journal of Nephrology|March 24, 2005
Renal disease in cardiovascular disorders: an underrecognized problemAlain Baumelou, Eric Bruckert, Corinne Bagnis, et al.
Kidney International|July 16, 2004
Antiretroviral and immunosuppressive drug-drug interactions: an updateHassane Izzedine, Vincent Launay-Vacher, Alain Baumelou, et al.
American Journal of Nephrology|June 28, 2005
FHD: an index to evaluate drug elimination by hemodialysisVincent Launay-Vacher, Hassane Izzedine, Alain Baumelou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2007
Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertensionHassane Izzedine, Olivier Rixe, Bertrand Billemont, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Bulletin De L'Academie Nationale De Medecine|August 1, 2008
[Public health benefits of non prescription medicines and self care]Alain Baumelou
The New England Journal of Medicine|January 9, 2010
Renal failure in cirrhosisHassane Izzedine, Alain Baumelou
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2007
Acute renal failure in HIV patientsHassane Izzedine, Alain Baumelou, Gilbert Deray
Kidney International|February 27, 2010
Idiopathic renal arteriovenous fistulaeHassane Izzedine, Alain Baumelou, Philippe Cluzel
Nephrologie & Therapeutique|March 22, 2007
[Hemoglobin target in hemodialysis patients]Lucile Mercadal, Gilbert Deray, Alain Baumelou
La Revue Du Praticien|March 8, 2006
[Medication use in older patients with chronic renal failure]Alain Baumelou, Vincent Launay Vacher, Marc Verny
American Journal of Nephrology|March 24, 2005
Renal disease in cardiovascular disorders: an underrecognized problemAlain Baumelou, Eric Bruckert, Corinne Bagnis, et al.
Kidney International|July 16, 2004
Antiretroviral and immunosuppressive drug-drug interactions: an updateHassane Izzedine, Vincent Launay-Vacher, Alain Baumelou, et al.
American Journal of Nephrology|June 28, 2005
FHD: an index to evaluate drug elimination by hemodialysisVincent Launay-Vacher, Hassane Izzedine, Alain Baumelou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 31, 2007
Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertensionHassane Izzedine, Olivier Rixe, Bertrand Billemont, et al.
Pageof 3